<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yue X</submitter><funding>NCRR NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>NCI NIH HHS</funding><funding>NIH HHS</funding><pagination>2011</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6494907</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10(1)</volume><pubmed_abstract>TET enzymes oxidize 5-methylcytosine to 5-hydroxymethylcytosine and other oxidized methylcytosines in DNA. Here we examine the role of TET proteins in regulatory T (Treg) cells. Tet2/3&lt;sup>fl/fl&lt;/sup>Foxp3&lt;sup>Cre&lt;/sup> mice lacking Tet2 and Tet3 in Treg cells develop inflammatory disease, and Treg cells from these mice show altered expression of Treg signature genes and upregulation of genes involved in cell cycle, DNA damage and cancer. In littermate mice with severe inflammation, both CD4&lt;sup>+&lt;/sup>Foxp3&lt;sup>+&lt;/sup> and CD4&lt;sup>+&lt;/sup>Foxp3&lt;sup>-&lt;/sup> cells show strong skewing towards Tfh/Th17 phenotypes. Wild-type Treg cells in mixed bone marrow chimeras and in Tet2/3&lt;sup>fl/fl&lt;/sup>Foxp3&lt;sup>WT/Cre&lt;/sup> heterozygous female mice are unable to rescue the aberrant properties of Tet2/3</pubmed_abstract><journal>Nature communications</journal><pubmed_title>Loss of TET2 and TET3 in regulatory T cells unleashes effector function.</pubmed_title><pmcid>PMC6494907</pmcid><funding_grant_id>R35 CA210043</funding_grant_id><funding_grant_id>R01 AI128589</funding_grant_id><funding_grant_id>S10 OD016262</funding_grant_id><funding_grant_id>S10 RR027366</funding_grant_id><funding_grant_id>AI 12858901</funding_grant_id><pubmed_authors>Rao A</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Yue X</pubmed_authors><pubmed_authors>Lio CJ</pubmed_authors><pubmed_authors>Samaniego-Castruita D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Loss of TET2 and TET3 in regulatory T cells unleashes effector function.</name><description>TET enzymes oxidize 5-methylcytosine to 5-hydroxymethylcytosine and other oxidized methylcytosines in DNA. Here we examine the role of TET proteins in regulatory T (Treg) cells. Tet2/3&lt;sup>fl/fl&lt;/sup>Foxp3&lt;sup>Cre&lt;/sup> mice lacking Tet2 and Tet3 in Treg cells develop inflammatory disease, and Treg cells from these mice show altered expression of Treg signature genes and upregulation of genes involved in cell cycle, DNA damage and cancer. In littermate mice with severe inflammation, both CD4&lt;sup>+&lt;/sup>Foxp3&lt;sup>+&lt;/sup> and CD4&lt;sup>+&lt;/sup>Foxp3&lt;sup>-&lt;/sup> cells show strong skewing towards Tfh/Th17 phenotypes. Wild-type Treg cells in mixed bone marrow chimeras and in Tet2/3&lt;sup>fl/fl&lt;/sup>Foxp3&lt;sup>WT/Cre&lt;/sup> heterozygous female mice are unable to rescue the aberrant properties of Tet2/3</description><dates><release>2019-01-01T00:00:00Z</release><publication>2019 May</publication><modification>2026-05-07T03:45:30.459Z</modification><creation>2019-06-06T23:10:25Z</creation></dates><accession>S-EPMC6494907</accession><cross_references><pubmed>31043609</pubmed><doi>10.1038/s41467-019-09541-y</doi></cross_references></HashMap>